Label: DOCUSATE SODIUM AND SENNA tablet, film coated

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated November 9, 2015

If you are a consumer or patient please visit this version.

  • OTC - ACTIVE INGREDIENT SECTION

    Active ingredients (in each tablet)
    Docusate Sodium 50 mg
    Sennosides 8.6 mg

  • OTC - PURPOSE SECTION

    Purposes
    Stool Softener
    Stimulant Laxative

  • OTC - KEEP OUT OF REACH OF CHILDREN SECTION

     KEEP OUT OF REACH OF CHILDREN SECTION

  • INDICATIONS & USAGE SECTION

    Uses

    • relieves occasional constipation
    • generally produces bowel movement in 6-12 hours
  • WARNINGS SECTION

    Warnings

  • OTC - DO NOT USE SECTION

    Do not use

    • for longer than one week
    • if you are taking mineral oil
    • when abdominal pain, nausea or vomiting are present
  • OTC - ASK DOCTOR SECTION

    Ask a doctor before use if you have noticed a sudden change in bowel habits that lasts over two weeks

  • OTC - ASK DOCTOR/PHARMACIST SECTION

    Ask a doctor or pharmacist before use if you are taking any other drug. Take this product two or more hours before or after other drugs. Laxatives may affect how other drugs work.

  • OTC - STOP USE SECTION

    Stop use and ask a doctor if

    • you have rectal bleeding
    • you fail to have a bowel movement after use of this product.

    These may indicate a serious condition.

  • OTC - PREGNANCY OR BREAST FEEDING SECTION

    If pregnant or breast-feeding, ask a health professional before use.
    Close

  • DOSAGE & ADMINISTRATION SECTION

    Directions
    adults and children 12 years and over: 2-4 tablets once daily or in divided doses
    children 6 to under 12 years: 1-2 tablets once daily or in divided doses
    children 2 to under 6 years: 1/2-1 tablet once daily or in divided doses
    children under 2 years: ask a doctor

  • STORAGE AND HANDLING SECTION

    Other information
    each tablet contains: calcium 20 mg, sodium 6 mg (LOW SODIUM)
    store at 20°-25°C (68°-77°F)

  • INACTIVE INGREDIENT SECTION

    Inactive ingredients carnauba wax, colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate dihydrate, FD-C blue #2 aluminum lake, FD-C red #40 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol (PEG), sodium benzoate, stearic acid, titanium dioxide

  • OTC - QUESTIONS SECTION

    Questions or comments?
    call 1-800-645-2158, 9 am - 5 pm ET, Monday - Friday

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    image description

  • INGREDIENTS AND APPEARANCE
    DOCUSATE SODIUM AND SENNA 
    docusate sodium and senna tablet, film coated
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:61919-518(NDC:0536-0355)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
    Inactive Ingredients
    Ingredient NameStrength
    CARNAUBA WAX (UNII: R12CBM0EIZ)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
    FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  
    HYPROMELLOSE 2910 (15 MPA.S) (UNII: 36SFW2JZ0W)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Product Characteristics
    ColorpurpleScoreno score
    ShapeROUNDSize10mm
    FlavorImprint Code TCL;131
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:61919-518-6060 in 1 BOTTLE
    1NDC:61919-518-3030 in 1 BOTTLE
    1NDC:61919-518-71100 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart33401/01/2014
    Labeler - DIRECT RX (079254320)
    Establishment
    NameAddressID/FEIBusiness Operations
    DIRECT RX079254320relabel(61919-518) , repack(61919-518)